Sensus Healthcare Debuts a New Operating Capabilities Solution

Sensus Healthcare Inc. is introducing to market Sensus Link, a cloud-based software and connectivity solution intended to expand advanced operating capabilities across the company’s SRT-100 system installed base.

Through the combination of a new point-of-care software solution with cloud-based connectivity features, Sensus Link enables SRT-100 system users to access enhanced workflow, treatment documentation, and operating intelligence. These capabilities historically were associated solely with more advanced image-guided and workstation platforms.

“Building upon recently enacted reimbursement codes that significantly improve physician economics for superficial radiotherapy, our priority is to broaden access to the full Sensus operating experience across our installed base,” Sensus Healthcare Chairman/CEO Joe Sardano stated. “Sensus Link is a natural next step and is the first of what we expect to be a series of enhancements under our Sensus Cloud initiative. It expands valuable capabilities to SRT-100 customers, supports improved serviceability and operating consistency, and creates a scalable recurring revenue opportunity tied to treatment workflows and required oversight services…we believe Sensus Link will strengthen our commercial offering across both direct purchase and Fair Deal Agreement customers. Importantly, it enables practices to adopt an enhanced operating platform while maintaining flexibility in how they acquire and use our technology.”

Sensus Healthcare is initiating a phased commercial rollout of Sensus Link this year. The company expects to offer Sensus Link to both new SRT-100 customers and eligible existing customers, subject to commercial terms, implementation readiness, and customer onboarding requirements.

“Sensus Link is the first of several exciting innovations that will allow us to offer a streamlined integration of the latest technological advancements to both existing and new SRT-100 customers,” Sensus Healthcare Chief Technology Officer Carlton Chow said.

Sensus Healthcare develops and delivers non-invasive treatments for skin cancer and keloids. Leveraging its cutting-edge superficial radiotherapy (SRT and IG-SRT) technology, the company provides healthcare providers with a patient-centric treatment platform. Sensus Healthcare offers solutions that are safe, precise, and adaptable to various clinical settings.